questionsmedicales.fr
Thérapeutique
Traitement médicamenteux
Voies d'administration de substances chimiques et des médicaments
Perfusions parentérales
Perfusions artérielles
Perfusions artérielles : Questions médicales fréquentes
Diagnostic
5
Perfusion
Diagnostic médical
Échographie Doppler
Angiographie
Évaluation clinique
Circulation sanguine
Critères d'admissibilité
État de santé
Symptômes
5
Infection
Réaction allergique
Réactions indésirables
Nausées
Prévention
5
Prévention des infections
Surveillance
Éducation des patients
Risques
Infection
Techniques aseptiques
Antécédents médicaux
État immunitaire
Évaluation des risques
Antécédents médicaux
Traitements
5
Anticoagulants
Vasodilatateurs
Durée de traitement
Perfusion
Cathéter
Administration de médicaments
Perfusion intraveineuse
Traitements oraux
Soins post-opératoires
Surveillance
Complications
5
Réaction allergique
Antihistaminiques
Complications
Traitement médical
Facteurs de risque
5
Âge avancé
Maladies chroniques
Tabagisme
Circulation sanguine
Maladies cardiovasculaires
Infections
Anticoagulants
Immunosuppresseurs
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Perfusions artérielles : Questions médicales les plus fréquentes",
"headline": "Perfusions artérielles : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Perfusions artérielles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-13",
"dateModified": "2026-06-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Perfusions artérielles"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perfusions parentérales",
"url": "https://questionsmedicales.fr/mesh/D007263",
"about": {
"@type": "MedicalCondition",
"name": "Perfusions parentérales",
"code": {
"@type": "MedicalCode",
"code": "D007263",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.510"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Perfusions artérielles",
"alternateName": "Infusions, Intra-Arterial",
"code": {
"@type": "MedicalCode",
"code": "D007261",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xunming Ji",
"url": "https://questionsmedicales.fr/author/Xunming%20Ji",
"affiliation": {
"@type": "Organization",
"name": "3Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China."
}
},
{
"@type": "Person",
"name": "Kenji Mitsudo",
"url": "https://questionsmedicales.fr/author/Kenji%20Mitsudo",
"affiliation": {
"@type": "Organization",
"name": "Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan."
}
},
{
"@type": "Person",
"name": "Longfei Wu",
"url": "https://questionsmedicales.fr/author/Longfei%20Wu",
"affiliation": {
"@type": "Organization",
"name": "1Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China."
}
},
{
"@type": "Person",
"name": "Stephen R Chen",
"url": "https://questionsmedicales.fr/author/Stephen%20R%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA."
}
},
{
"@type": "Person",
"name": "Melissa M Chen",
"url": "https://questionsmedicales.fr/author/Melissa%20M%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Intra-arterial PSMA injection using hepatic arterial infusion pump in intrahepatic cholangiocarcinoma: a proof-of-concept study.",
"datePublished": "2024-08-01",
"url": "https://questionsmedicales.fr/article/39090480",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s41747-024-00496-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Local thrombolytics via balloon-assisted intra-arterial infusion as rescue therapy for thromboembolism during endovascular coil embolisation.",
"datePublished": "2023-10-24",
"url": "https://questionsmedicales.fr/article/37879706",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-256134"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.",
"datePublished": "2023-11-24",
"url": "https://questionsmedicales.fr/article/38008195",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijrobp.2023.11.031"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer.",
"datePublished": "2024-09-16",
"url": "https://questionsmedicales.fr/article/39283505",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00520-024-08807-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.",
"datePublished": "2024-05-10",
"url": "https://questionsmedicales.fr/article/38799453",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1397827"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Voies d'administration de substances chimiques et des médicaments",
"item": "https://questionsmedicales.fr/mesh/D004333"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perfusions parentérales",
"item": "https://questionsmedicales.fr/mesh/D007263"
},
{
"@type": "ListItem",
"position": 6,
"name": "Perfusions artérielles",
"item": "https://questionsmedicales.fr/mesh/D007261"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Perfusions artérielles - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Perfusions artérielles",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Perfusions artérielles",
"description": "Comment diagnostiquer une nécessité de perfusion artérielle ?\nQuels tests sont utilisés pour évaluer la circulation sanguine ?\nQuels signes indiquent une perfusion artérielle nécessaire ?\nComment évaluer l'efficacité d'une perfusion artérielle ?\nQuels sont les critères d'admissibilité pour une perfusion ?",
"url": "https://questionsmedicales.fr/mesh/D007261#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Perfusions artérielles",
"description": "Quels symptômes nécessitent une perfusion artérielle ?\nComment reconnaître une ischémie aiguë ?\nQuels signes indiquent une complication de perfusion ?\nQuels symptômes peuvent survenir après une perfusion ?\nComment les patients réagissent-ils aux perfusions ?",
"url": "https://questionsmedicales.fr/mesh/D007261#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Perfusions artérielles",
"description": "Comment prévenir les complications de perfusion artérielle ?\nQuels conseils donner aux patients avant une perfusion ?\nComment réduire le risque d'infection lors d'une perfusion ?\nQuels facteurs de risque doivent être surveillés ?\nComment évaluer le besoin de perfusion préventive ?",
"url": "https://questionsmedicales.fr/mesh/D007261#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Perfusions artérielles",
"description": "Quels médicaments sont souvent administrés par perfusion artérielle ?\nQuelle est la durée typique d'une perfusion artérielle ?\nComment se déroule une perfusion artérielle ?\nQuelles sont les alternatives à la perfusion artérielle ?\nQuels soins sont nécessaires après une perfusion ?",
"url": "https://questionsmedicales.fr/mesh/D007261#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Perfusions artérielles",
"description": "Quelles sont les complications possibles d'une perfusion artérielle ?\nComment reconnaître une thrombose après une perfusion ?\nQuels signes d'infection doivent alerter ?\nComment gérer une réaction allergique à une perfusion ?\nQuelles mesures prendre en cas de complications ?",
"url": "https://questionsmedicales.fr/mesh/D007261#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Perfusions artérielles",
"description": "Quels facteurs augmentent le risque de complications ?\nComment le tabagisme influence-t-il les perfusions ?\nQuels antécédents médicaux sont préoccupants ?\nComment l'obésité affecte-t-elle les perfusions ?\nQuels médicaments augmentent les risques lors d'une perfusion ?",
"url": "https://questionsmedicales.fr/mesh/D007261#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une nécessité de perfusion artérielle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic est basé sur l'évaluation clinique et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la circulation sanguine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie Doppler et l'angiographie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une perfusion artérielle nécessaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs aiguës, une ischémie ou des lésions tissulaires peuvent indiquer ce besoin."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'une perfusion artérielle ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration des symptômes et des tests de circulation."
}
},
{
"@type": "Question",
"name": "Quels sont les critères d'admissibilité pour une perfusion ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'état de santé général et la nature de la maladie traitée."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une perfusion artérielle ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs sévères, des engourdissements ou des signes d'ischémie peuvent nécessiter une perfusion."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une ischémie aiguë ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ischémie aiguë se manifeste par une douleur intense, une pâleur et une perte de fonction."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication de perfusion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs croissantes, des changements de couleur ou un gonflement peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir après une perfusion ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs au site de perfusion, des infections ou des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les patients réagissent-ils aux perfusions ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions varient, mais peuvent inclure des douleurs, des nausées ou des vertiges."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications de perfusion artérielle ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une technique stérile, une surveillance attentive et une évaluation régulière sont essentielles."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux patients avant une perfusion ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur le processus, les risques et les soins post-perfusion est crucial."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'infection lors d'une perfusion ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des techniques aseptiques et surveiller le site de perfusion régulièrement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque doivent être surveillés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux, l'état immunitaire et les allergies doivent être surveillés."
}
},
{
"@type": "Question",
"name": "Comment évaluer le besoin de perfusion préventive ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les facteurs de risque et les antécédents médicaux pour déterminer le besoin."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont souvent administrés par perfusion artérielle ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticoagulants, des vasodilatateurs et des antibiotiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est la durée typique d'une perfusion artérielle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée varie selon le traitement, généralement de quelques heures à plusieurs jours."
}
},
{
"@type": "Question",
"name": "Comment se déroule une perfusion artérielle ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La procédure implique l'insertion d'un cathéter dans l'artère et l'administration du médicament."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives à la perfusion artérielle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les alternatives incluent les perfusions intraveineuses ou les traitements oraux."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après une perfusion ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillance du site de perfusion, gestion de la douleur et suivi des signes vitaux sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une perfusion artérielle ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'infection, la thrombose et les lésions nerveuses."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une thrombose après une perfusion ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, un gonflement et une rougeur au site de perfusion peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection doivent alerter ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et écoulement au site de perfusion sont des signes d'infection."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique à une perfusion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser immédiatement la perfusion et administrer des antihistaminiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles mesures prendre en cas de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un médecin immédiatement et suivre les protocoles de traitement appropriés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies chroniques et l'immunosuppression augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme influence-t-il les perfusions ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut altérer la circulation sanguine et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont préoccupants ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de maladies cardiovasculaires ou d'infections sont préoccupants."
}
},
{
"@type": "Question",
"name": "Comment l'obésité affecte-t-elle les perfusions ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité peut compliquer l'accès vasculaire et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent les risques lors d'une perfusion ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants et les immunosuppresseurs peuvent augmenter les risques de complications."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/06/2026
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
3Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Publications dans "Perfusions artérielles" :
5 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publications dans "Perfusions artérielles" :
4 publications dans cette catégorie
Affiliations :
1Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Publications dans "Perfusions artérielles" :
4 publications dans cette catégorie
Affiliations :
Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publications dans "Perfusions artérielles" :
4 publications dans cette catégorie
Affiliations :
Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publications dans "Perfusions artérielles" :
4 publications dans cette catégorie
Affiliations :
Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publications dans "Perfusions artérielles" :
4 publications dans cette catégorie
Affiliations :
Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA ptkan@utmb.edu.
Publications dans "Perfusions artérielles" :
4 publications dans cette catégorie
Affiliations :
Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
1Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
1Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan koizumi-tky@umin.ac.jp.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
Department of Radiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
Publications dans "Perfusions artérielles" :
3 publications dans cette catégorie
Affiliations :
Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania. Electronic address: carolshields@gmail.com.
Publications dans "Perfusions artérielles" :
2 publications dans cette catégorie
Affiliations :
Interventional and Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
Department of Biomedical Sciences and Clinical Oncology, University of Bari Aldo Moro, 70124 Bari, Italy.
Publications dans "Perfusions artérielles" :
2 publications dans cette catégorie
Affiliations :
Interventional and Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
Publications dans "Perfusions artérielles" :
2 publications dans cette catégorie
Affiliations :
Interventional and Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
Publications dans "Perfusions artérielles" :
Prostate-specific membrane antigen (PSMA) targeted tracers show increased uptake in several malignancies, indicating a potential for peptide radioligand therapy. Intra-arterial injection of radiotrace...
Thromboembolism is the most frequent complication of coil embolisation for intracranial aneurysm. Complications of thromboembolism can lead to stroke and have a serious impact on sequelae and mortalit...
Locally advanced maxillary sinus cancers require radical surgery as a standard treatment, but this often results in significant disfigurement and impairment of function. JCOG1212 seeks to evaluate the...
Patients received 100 mg/m...
From April 2014 to August 2018, 65 patients were registered in the T4a cohort from 18 institutions, consisting of 54 men and 11 women with a median age of 64 years (range, 40-78 years) and Eastern Coo...
We demonstrated that RADPLAT showed favorable results for patients with T4aN0M0 maxillary sinus squamous cell carcinomas compared with the historical control for 3-year OS in surgery, which was from a...
Oxaliplatin, a major drug in metastatic colorectal cancer (mCRC), is responsible for cumulative, dose-limiting peripheral neuropathy (PN). Whether the hepatic arterial infusion (HAI) route can limit o...
We compared the frequency and severity of PN in oxaliplatin-naive patients with mCRC included in trials that evaluated treatment with oxaliplatin administered either by HAI (ACCORD 04, CHOICE, OSCAR, ...
A total of 363 patients were included (IV, 300; HAI, 63). In total, 180 patients in the IV group (60%) and 30 patients in the HAI group (48%) developed clinically significant PN, with no significant d...
The administration of oxaliplatin HAI rather than IV in the treatment of mCRC does not reduce the incidence, precocity, and severity of PN....
The prognosis for unresectable intrahepatic cholangiocarcinoma (ICC) is poor and the efficacy of traditional chemotherapy remains unsatisfactory. Hepatic arterial infusion chemotherapy (HAIC) with oxa...
Between July 2021 and July 2023, patients with unresectable ICC who initially received lenvatinib plus durvalumab combined with FOLFOX-HAIC at the Sun Yat-Sen University Cancer Center (SYSUCC) were re...
A total of 28 eligible patients were enrolled. The objective response rates (ORRs) based on mRECIST and RECIST 1.1 criteria were 65.2% and 39.1%, respectively. The median OS was 17.9 months (95% CI, 5...
Lenvatinib plus durvalumab combined with FOLFOX-HAIC showed promising antitumor activity and manageable AEs in patients with treatment-naive unresectable ICC. This regimen may be suitable as a novel f...
Retinoblastoma (Rb) is the most common primary ocular malignancy of childhood. Left untreated, it is 100% fatal and carries a substantial risk of impaired vision and removal of one or both eyes. Intra...
A retrospective chart review was conducted of 571 patients (697 eyes) and 2391 successful IAC sessions over 15 years. This cohort was separated into three 5-year periods (P1, P2, P3) to assess trends ...
From a total of 2402 attempted IAC sessions, there were 2391 successful IAC deliveries, consistent with a 99.5% success rate. The rate of successful super-selective catheterizations over the three per...
The overall rate of successful catheterization and IAC started high and has improved over 15 years, and catheterization-related complications are rare. There has been a significant trend towards tripl...
Most patients with advanced hepatocellular carcinoma (HCC) ultimately experience tumor progression after first-line systemic therapies. Systemic therapy is generally recommended as second-line treatme...
Vessels encapsulating tumor clusters (VETC) is a novel vascular pattern structurally and functionally distinct from microvascular invasion (MVI) in hepatocellular carcinoma (HCC). This study aims to e...
From January 2016 to December 2017, 145 patients receiving HAIC as the initial treatment for unresectable HCC were enrolled and stratified into two groups according to their VETC status. Overall survi...
The patients were divided into two groups: VETC...
VETC status correlates remarkably well with the tumor response and long-term survival in patients undergoing HAIC. It may be a promising efficacy predictor and help identify patients who will benefit ...
This study aimed to evaluate the efficacy and safety of sequential treatment of continuous transcatheter hepatic artery infusion chemotherapy (HAIC) with systemic capecitabine monotherapy and camreliz...
This study retrospectively analyzed patients with unresectable HCCA admitted to Linyi Cancer Hospital in Shandong Province from October 2019 to December 2021. All enrolled patients were treated with H...
This study included 34 patients, ORR was 61.76% (21/34), and DCR was 97.06% (33/34) after two HAIC cycles. The median follow-up time was 17.5 months, with an average of 18.32 ± 8.06 months, and the me...
HAIC sequentially combined with systemic capecitabine chemotherapy and a programmed death-1 inhibitor displayed favorable effects for unresectable HCCA, with controllable adverse reactions....
The prognosis of hepatocellular carcinoma (HCC) with macrovascular invasion(MaVI)is poor, and the treatment is limited. This study aims to explore the efficacy and safety of hepatic arterial infusion ...
From July 2020 to February 2022, we retrospectively analyzed consecutive patients with HCC with MaVI who received hepatic arterial infusion FOLFOX(oxaliplatin, 5-fluorouracil, and leucovorin)combined ...
Thirty-two patients with HCC complicated with MaVI were recruited from the Second Affiliated Hospital of Nanchang University. Among the patients treated with HAIC combined with lenvatinib and PD-1 inh...
Hepatic arterial infusion of FOLFOX combined with lenvatinib and PD-1 inhibitor as the first-line treatment for HCC complicated with MaVI is effective, and adverse reactions are tolerable....